Adderall Shortage 2026: Where Things Stand Right Now

If you are reading this, there is a good chance you just heard "we don't have it" at a pharmacy counter, or you are bracing for it before your next refill.

One thing up front. I live in Turkey, where Adderall is not sold, and I have never taken it. This is a research-based explainer built on what the FDA and the DEA have published. Every status claim below comes with the date I checked it, because a shortage list changes week to week.

If you want the basics of the drug itself first, start with what Adderall is and how it works.

Is there still an Adderall shortage?

Yes, but it looks different from 2022 and 2023.

On October 23, 2026, I checked the FDA Drug Shortages Database. Immediate-release amphetamine mixed salts tablets, the generic form of Adderall, were still listed as a current shortage. The listing was first posted on October 12, 2022, which means it has now been open for four years.

The FDA's data had last been updated on October 22, 2026, and each company's entry had been reverified between August 20 and October 21, 2026.

What changed is the shape of it. Back in late 2022, the problem was broad. Now many strengths are available from several manufacturers, while specific strengths from specific companies are out. So the real answer to "is there a shortage" is often "it depends on your strength, your pharmacy and your zip code."

What the FDA list showed on October 23, 2026

Here is how the 73 listed immediate-release products broke down. The FDA lists them by company, strength and package, so one strength can appear several times.

Status in the FDA database	Number of listed products
Available	45
Limited availability	9
Unavailable	19
Total, from 11 companies	73

A few details stood out.

• The reasons given. Where a company gave a reason, it was most often "shortage of an active ingredient." A few cited a demand increase or "other."
• The recovery estimates. For products that were out, companies estimated recovery anywhere from October 2026 to April 2027, and several said TBD.
• Adderall XR. Extended-release amphetamine mixed salts capsules did not show up as a current shortage in the data I checked. That does not guarantee your pharmacy has your strength, but the national listing was about the tablets.

How it started in 2022

On October 12, 2022, the FDA announced the shortage publicly. Its notice said that one manufacturer, Teva, was having ongoing intermittent manufacturing delays, and that the other manufacturers could not make enough to cover U.S. demand on their own.

In that same notice, the FDA pointed out that alternatives existed, including the extended-release version, and told patients to work with their health care professionals on the best option.

It sounded like a short-term production problem. It turned out to be the start of a much longer story, because demand had been climbing for years.

A CDC report published in March 2023 looked at insurance claims from 2016 to 2021. The share of people filling stimulant prescriptions rose from 3.6 percent to 4.1 percent. Between 2020 and 2021 alone, fills among women rose by 13.9 percent, and the biggest jumps were among adults aged 25 to 44. The authors noted that easier telehealth access during the pandemic may have played a part, but their data could not prove that.

More adults were being diagnosed and treated. If you are one of them, that was not the problem. The supply system simply was not built for it.

Why the shortage lasted so long

Adderall is a Schedule II controlled substance. That means the DEA sets a yearly limit on how much amphetamine can be produced in the United States, called the aggregate production quota, and gives each manufacturer its own share.

On August 1, 2023, the FDA and the DEA published a joint letter to the public about the stimulant shortages. Three points from it explain a lot:

1. Overall stimulant dispensing in the U.S. rose by 45.5 percent from 2012 to 2021.
2. In 2022, manufacturers sold only about 70 percent of their amphetamine quota, which left roughly 1 billion doses that could have been made but were not.
3. The agencies asked companies to produce up to their quotas, or to give up the unused quota so the DEA could hand it to someone who would use it.

Neither agency makes drugs. They can adjust quotas and ask companies to act, but the actual pills depend on manufacturers, ingredient suppliers and distributors.

The shortage also spread. In July 2023, the FDA list added lisdexamfetamine, the active ingredient in Vyvanse, and extended-release methylphenidate tablets. When one stimulant runs short, people switch to another, and demand moves with them.

What the DEA has changed since then

The quota numbers have gone up, in steps.

• September 2024. The DEA raised the 2024 quota for lisdexamfetamine and for the d-amphetamine used to make it.
• September 2025. Another increase for lisdexamfetamine and d-amphetamine for conversion, citing a shortage of lisdexamfetamine capsules and chewable tablets.
• October 2, 2025. The DEA raised the 2025 quota for d-amphetamine for sale from 21,200,000 grams to 26,450,000 grams, an increase of about 25 percent. It raised methylphenidate for sale as well.
• January 5, 2026. The final 2026 quotas kept d-amphetamine for sale at 26,450,000 grams and set d,l-amphetamine at 24,234,443 grams.

In that 2026 notice, the DEA also answered a public comment claiming that it gave out the two forms of amphetamine in a fixed one-to-one ratio, which would make Adderall impossible to produce properly. The DEA said that is not how it allocates quota.

Telehealth is the other piece. The pandemic rule that lets a clinician prescribe Schedule II drugs over telehealth without an in-person visit first has been extended four times. The latest extension, published December 31, 2025, runs through December 31, 2026. As of October 23, 2026, I could not find a newer rule in the Federal Register, so if you get your prescription through telehealth, check for updates before the end of the year.

Other ADHD medications on the shortage list

Adderall is not the only one. This is what the same FDA database showed on October 23, 2026.

Medication (active ingredient)	Listed since	Status on Oct 23, 2026
Adderall IR (amphetamine mixed salts tablets)	Oct 12, 2022	Current shortage, 19 of 73 products unavailable
Adderall XR (amphetamine mixed salts ER capsules)	Not listed	No current shortage entry
Vyvanse (lisdexamfetamine capsules and chewables)	Jul 14, 2023	Current shortage, 36 of 100 products limited, none unavailable
Methylphenidate ER tablets (Concerta and generics)	Jul 26, 2023	Current shortage, 6 of 34 products unavailable
Methylphenidate ER film (patch)	Feb 28, 2025	Current shortage, all 4 products listed as available
Dexmethylphenidate (Focalin)	Not listed	No current shortage entry
Atomoxetine (Strattera)	Not listed	No current shortage entry

For how these medications compare to each other, see the list of ADHD medications.

What to do when your pharmacy is out

The steps above in the how-to box are the short version. A few things make them work better.

Start early. Schedule II prescriptions cannot be refilled the way other prescriptions can, so every fill is a new prescription. Give yourself a few days of margin before you run out, not a few hours.

Ask about strength and manufacturer. "Do you have Adderall?" gets a yes or no. "Do you have amphetamine salts 10 mg from any manufacturer, or a different strength?" gets you information your prescriber can actually use. Do not change the strength or the number of tablets on your own. Just collect the facts.

Use the one-time transfer. Since August 28, 2023, DEA rules allow an electronic prescription for a Schedule II to V controlled substance to be transferred once, at your request, between retail pharmacies for its first fill. State law and pharmacy policy still apply, so ask.

Work with one pharmacy if you can. A pharmacist who knows you may tell you when their delivery day is, or set your order aside. Calling ten pharmacies every month is exhausting, and that exhaustion is real work.

Questions to ask your prescriber

Medication decisions belong with the person who prescribes for you. But you can walk in with good questions.

• Is a different strength of the same medication available that could work, for example two smaller tablets instead of one larger one?
• Would the extended-release form make sense for me right now?
• Is there another stimulant that is easier to find in my area? (See Vyvanse vs Adderall for how two common options differ.)
• Would a non-stimulant medication be worth considering, given that they are not on the shortage list right now?
• If I have to go without for a while, what should I watch for, and when should I call?

If the cost of switching is the barrier, the guide to ADHD medication without insurance covers that side.

What not to do

Buying pills online or from someone else. In its 2026 quota notice, the DEA repeated its warning that medications from unregistered internet sources may be fake or laced with illicit fentanyl. A pill that looks like Adderall is not proof that it is.

Taking someone else's medication. Even with the same active ingredient, the form, strength and timing are set for one person.

Stretching your supply without telling anyone. Skipping days or cutting doses to make a bottle last longer can be a reasonable plan, but only if your prescriber knows about it and agrees.

If you have to go without for a while

Stimulants work while they are in your system, so when you stop, the symptoms they were covering usually come back. That return is the medication wearing off. It is not a sign that you have failed. I wrote about this in more detail in what happens if you stop ADHD medication.

A gap week is not the week to start a big project. Pick the two or three things that truly have to happen, put them in writing somewhere you will see them, and let the rest wait. Outside structure, like timers, a body double or a fixed morning routine, does some of the work the medication was doing. The guide to ADHD treatment without medication has more on this.

Watch the coffee, too. Many people with ADHD lean harder on caffeine when their medication is missing, and too much of it brings its own problems with sleep and anxiety. I covered that pattern in caffeine and self-medication in ADHD.

How to check the status yourself

The FDA Drug Shortages Database is public. Search for "amphetamine" and open the entry for the tablets. Each company's line shows the strength, whether it is available, limited or unavailable, the reason, and the estimated recovery date. The page also lists a phone number for each company.

Check it before calling your prescriber. Saying "the FDA list shows the 20 mg from these two companies as available" can turn a long phone call into a short one.

Supply problems with ADHD medication are not only an American story. Methylphenidate shortages happen in Turkey too, and I wrote about that in ADHD medication out of stock. The details differ from country to country, but the lesson is the same everywhere: the time you spend hunting for a prescription is a real cost, and planning ahead is the one part of it you can control.